Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3086% above fair value
$114.63−1.25 (-1.07%)
Close on Nov 20, 2026Market cap $23.36BP/E 61.0Yield –
Incyte free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Incyte's free cash flow for the twelve months ending Dec 31, 2022 was $892.11M, up 56.9% year over year. For fiscal 2022 it was $892.11M, up 56.9% from the year before. The highest annual figure on record is $892.11M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $892.11M | +56.9% |
| FY2021 | Dec 31, 2021 | $568.48M | – |
| FY2020 | Dec 31, 2020 | -$311.98M | -149.3% |
| FY2019 | Dec 31, 2019 | $632.59M | +140.8% |
| FY2018 | Dec 31, 2018 | $262.74M | – |
| FY2017 | Dec 31, 2017 | -$204.01M | -210.6% |
| FY2016 | Dec 31, 2016 | $184.48M | +191.0% |
| FY2015 | Dec 31, 2015 | $63.41M | – |
| FY2014 | Dec 31, 2014 | -$1.62M | -133.0% |
| FY2013 | Dec 31, 2013 | $4.91M | – |
| FY2012 | Dec 31, 2012 | -$97.67M | – |
| FY2011 | Dec 31, 2011 | -$165.51M | -276.4% |
| FY2010 | Dec 31, 2010 | $93.83M | +683.8% |
| FY2009 | Dec 31, 2009 | $11.97M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $262.39M | +224.4% |
| Q3 FY2022 | Sep 30, 2022 | $268.57M | +20.5% |
| Q2 FY2022 | Jun 30, 2022 | $162.41M | +52.3% |
| Q1 FY2022 | Mar 31, 2022 | $198.74M | +25.8% |
| Q4 FY2021 | Dec 31, 2021 | $80.89M | +44.7% |
| Q3 FY2021 | Sep 30, 2021 | $222.95M | +72.4% |
| Q2 FY2021 | Jun 30, 2021 | $106.64M | -52.7% |
| Q1 FY2021 | Mar 31, 2021 | $158.01M | – |
| Q4 FY2020 | Dec 31, 2020 | $55.89M | -45.4% |
| Q3 FY2020 | Sep 30, 2020 | $129.29M | -55.0% |
| Q2 FY2020 | Jun 30, 2020 | $225.52M | +113.4% |
| Q1 FY2020 | Mar 31, 2020 | -$722.68M | -626.0% |
| Q4 FY2019 | Dec 31, 2019 | $102.30M | +74.7% |
| Q3 FY2019 | Sep 30, 2019 | $287.23M | +64.8% |
| Q2 FY2019 | Jun 30, 2019 | $105.67M | +388.9% |
| Q1 FY2019 | Mar 31, 2019 | $137.40M | +1565.8% |
| Q4 FY2018 | Dec 31, 2018 | $58.56M | – |
| Q3 FY2018 | Sep 30, 2018 | $174.33M | +826.3% |
| Q2 FY2018 | Jun 30, 2018 | $21.61M | -75.0% |
| Q1 FY2018 | Mar 31, 2018 | $8.25M | – |
| Q4 FY2017 | Dec 31, 2017 | -$114.52M | -245.9% |
| Q3 FY2017 | Sep 30, 2017 | $18.82M | – |
| Q2 FY2017 | Jun 30, 2017 | $86.30M | – |
| Q1 FY2017 | Mar 31, 2017 | -$194.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $78.51M | – |
See a number that looks wrong?